Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DelShen Therapeutics is a Canadian licensed producer of medical and recreational cannabis, based in Kirkland Lake, Ontario. As a subsidiary of 48North Cannabis Corp (now part of Tilray Brands), the company operates a 40,000-square-foot indoor cultivation facility designed for high-quality, consistent production. DelShen holds federal licenses for cultivation, processing, and medical sales, focusing on the health and wellness segment of the cannabis market. Their operations emphasize controlled environment agriculture and the development of diverse cannabinoid profiles for therapeutic use. The company's products are distributed across Canada through both medical and adult-use retail channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DelShen Therapeutics.